|
Index of reports
> Death (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Atrovent (Ipratropium) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Atrovent side effects in male
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-03-30
Patient: male, weighing 97.0 kg (213.4 pounds)
Reactions: Pneumothorax
Adverse event resulted in: death
Drug(s) suspected as cause:
Atrovent
Possible Atrovent side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-15
Patient: male
Reactions: Death, Confusional State, Renal Failure, Tachyarrhythmia, Polyuria, Convulsion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Theophylline
Dosage: 800 mg
Administration route: Oral
End date: 2012-01-05
Immune Globulin NOS
End date: 2011-12-28
Trandolapril
Administration route: Oral
End date: 2012-01-05
Atrovent
End date: 2012-01-05
Fluticasone Propionate / Salmeterol
End date: 2012-01-05
Other drugs received by patient: Mirtazapine
Possible Atrovent side effects in male
Reported by a physician from France on 2012-02-28
Patient: male
Reactions: Confusional State, Bradypnoea, Polyuria, Respiratory Depression, Multi-Organ Failure, Death, Overdose, Streptococcal Sepsis, Tachypnoea, Unevaluable Event, Use of Accessory Respiratory Muscles, Decreased Appetite, Hypovolaemia, Vomiting, Metabolic Acidosis, Tachyarrhythmia, Hyperglycaemia, Hypotension, Atrial Fibrillation, Livedo Reticularis, Convulsion, Renal Failure, Diarrhoea, Dehydration, Gastroenteritis, Depressed Level of Consciousness, Skin Necrosis, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Aminophylline
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Fluticasone Propionate / Salmeterol
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Trandolapril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Immune Globulin (Human)
Indication: Product Used FOR Unknown Indication
End date: 2011-12-28
Atrovent
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Other drugs received by patient: Mirtazapine; Xanax; Prednisone TAB; Lansoprazole; Calcidose Vitamine D; Bricanyl; Gaviscon; Desloratadine; Potassium Chloride; Folic Acid
Possible Atrovent side effects in male
Reported by a physician from France on 2012-02-24
Patient: male
Reactions: Confusional State, Bradypnoea, Polyuria, Respiratory Depression, Multi-Organ Failure, Death, Overdose, Streptococcal Sepsis, Tachypnoea, Unevaluable Event, Use of Accessory Respiratory Muscles, Decreased Appetite, Hypovolaemia, Metabolic Acidosis, Vomiting, Tachyarrhythmia, Hypotension, Hyperglycaemia, Atrial Fibrillation, Livedo Reticularis, Convulsion, Renal Failure, Diarrhoea, Dehydration, Depressed Level of Consciousness, Gastroenteritis, Skin Necrosis, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Aminophylline
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Atrovent
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Fluticasone Propionate / Salmeterol
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Immunoglobulins, Normal Human
Indication: Product Used FOR Unknown Indication
End date: 2011-12-28
Trandolapril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Other drugs received by patient: Xanax; Bricanyl; Potassium Chloride; Calcidose Vitamine D; Prednisone TAB; Mirtazapine; Gaviscon; Lansoprazole; Folic Acid; Desloratadine
|
